
Cardiac Biomarkers and Left Ventricular Hypertrophy in Relation to Outcomes in Patients With Atrial Fibrillation: Experiences From the RE ‐ LY Trial
Author(s) -
Hijazi Ziad,
Verdecchia Paolo,
Oldgren Jonas,
Andersson Ulrika,
Reboldi Gianpaolo,
Di Pasquale Giuseppe,
Mazzotta Giovanni,
Angeli Fabio,
Eikelboom John W.,
Ezekowitz Michael D.,
Connolly Stuart J.,
Yusuf Salim,
Wallentin Lars
Publication year - 2019
Publication title -
journal of the american heart association
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.494
H-Index - 85
ISSN - 2047-9980
DOI - 10.1161/jaha.118.010107
Subject(s) - medicine , cardiology , atrial fibrillation , hazard ratio , left ventricular hypertrophy , natriuretic peptide , troponin , troponin t , proportional hazards model , stroke (engine) , gdf15 , heart failure , biomarker , myocardial infarction , confidence interval , blood pressure , mechanical engineering , biochemistry , chemistry , engineering